StockData
CapsoVision, Inc logo

CapsoVision, Inc (CV) stock

CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30718% above fair value
$6.47+0.44 (+7.30%)

Close on Nov 16, 2026Market cap $323.80MP/E –Yield –

CapsoVision profit margin

Profit margin (net margin) is net income as a percentage of revenue.

CapsoVision's profit margin for the twelve months ending Jun 30, 2026 was -214.7%. For fiscal 2025 it was -186.8%, against -169.3% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-186.8%−17.5
FY2024Dec 31, 2024-169.3%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-205.4%−65.8
Q1 FY2026Mar 31, 2026-251.9%−58.8
Q4 FY2025Dec 31, 2025-188.7%−54.3
Q3 FY2025Sep 30, 2025-223.9%−28.5
Q2 FY2025Jun 30, 2025-139.5%+45.7
Q1 FY2025Mar 31, 2025-193.1%–
Q4 FY2024Dec 31, 2024-134.4%–
Q3 FY2024Sep 30, 2024-195.3%–
Q2 FY2024Jun 30, 2024-185.2%–

More CapsoVision figures

See a number that looks wrong?